1.23犀牛财经早报：头部私募大手笔加仓谋攻2026年结构性机会

Group 1 - Leading private equity firms are increasing their positions, with stock private equity positions rising above 81% as of January 9, 2026, marking an increase of over 1 percentage point from the end of 2025 [1] - The first week of 2026 saw a significant increase in positions among large private equity firms, with an average increase of nearly 8 percentage points [1] - The capital market is expected to continue its structural trends in 2026, driven by reduced external uncertainties, low interest rates, and solidifying corporate earnings [1] Group 2 - The A-share market has seen a significant reduction in the total shares of major broad-based ETFs, indicating a major reallocation by the "national team" [2] - The latest public fund quarterly reports confirm that major ETFs like Huatai-PB CSI 300 ETF and Huaxia SSE 50 ETF have seen their total shares drop below the holdings of the central financial authority [2] Group 3 - Over 50 biopharmaceutical companies have released performance forecasts for 2025, with nearly half indicating positive expectations [3] - Leading CXO companies, such as WuXi AppTec, are projected to achieve significant revenue growth, with an expected revenue of approximately 45.46 billion yuan, a year-on-year increase of about 15.84% [3] - The biopharmaceutical industry is anticipated to enter a new phase of high-quality development in 2026, supported by ongoing policy and financing improvements [3] Group 4 - The gold jewelry market is experiencing a shift from weight-based pricing to value-based pricing, with brands introducing fixed-price products that appeal to younger consumers [4] - Upstream companies are benefiting from rising gold prices, which are expected to enhance profitability [4] Group 5 - The commercial space sector in China is entering a new phase focused on large-scale launches and commercial viability, with significant advancements expected in the next 3 to 5 years [5] - In 2025, China's commercial space sector completed 50 launches, accounting for 54% of total space launches, indicating a rapid acceleration in commercialization [5] Group 6 - The domestic GPU manufacturer, Shanghai Suiruan Technology, has received approval for its IPO on the Sci-Tech Innovation Board, aiming to raise 6 billion yuan [6] - The company is part of a growing trend of domestic tech firms seeking public funding to support their growth [6]